Skip to main content

STIFEL FINANCIAL CORP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 720672 ST. LOUIS, MO

Position in TEVA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$6,252,760
+$2,952,243 QoQ
Shares Held
207,595
+96.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 97.20802524145572.ToString("F0")% Shared 0.ToString("F0")% None 2.791974758544281.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $156,487,204 across 25 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 TEVA
Teva Pharmaceutical Industries Ltd
This page
207,595 $6,252,760

All Filings in TEVA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,252,760 207,595
2025-12-31 $3,300,517 105,752
2025-09-30 $1,843,431 91,259
2025-06-30 $1,558,846 93,010
2025-03-31 $1,461,194 95,068
2024-12-31 $1,950,053 88,478
2024-09-30 $1,196,364 66,391
2024-06-30 $700,504 43,108
2024-03-31 $539,636 38,245
2023-12-31 $363,917 34,858
2023-09-30 $394,382 38,665
2023-06-30 $394,337 52,369
2023-03-31 $414,038 46,784
2022-12-31 $390,947 42,867
2022-09-30 $246,496 30,545
2022-06-30 $227,643 30,272
2022-03-31 $282,854 30,123
2021-12-31 $297,979 37,201
2021-09-30 $321,527 33,011
2021-06-30 $355,032 35,862
2021-03-31 $437,203 37,886
2020-12-31 $430,023 44,562
2020-09-30 $450,976 50,053
2020-06-30 $559,473 45,375
2020-03-31 $485,494 54,064